KR20070040424A - 신속히 붕해되는 메틸셀룰로오스 정제 - Google Patents

신속히 붕해되는 메틸셀룰로오스 정제 Download PDF

Info

Publication number
KR20070040424A
KR20070040424A KR1020077007455A KR20077007455A KR20070040424A KR 20070040424 A KR20070040424 A KR 20070040424A KR 1020077007455 A KR1020077007455 A KR 1020077007455A KR 20077007455 A KR20077007455 A KR 20077007455A KR 20070040424 A KR20070040424 A KR 20070040424A
Authority
KR
South Korea
Prior art keywords
tablet
methylcellulose
sodium
disintegrant
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020077007455A
Other languages
English (en)
Korean (ko)
Inventor
브르스 대기
나레쉬 아이. 메타
프리야쉬리 나야크
Original Assignee
스미스클라인 비참 코포레이션
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 스미스클라인 비참 코포레이션 filed Critical 스미스클라인 비참 코포레이션
Publication of KR20070040424A publication Critical patent/KR20070040424A/ko
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/717—Celluloses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
KR1020077007455A 1997-08-22 1998-08-21 신속히 붕해되는 메틸셀룰로오스 정제 Ceased KR20070040424A (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US5689997P 1997-08-22 1997-08-22
US8766298P 1998-06-02 1998-06-02
US60/087,662 1998-06-02
US60/056,899 1998-06-02

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
KR1020007001825A Division KR100743767B1 (ko) 1997-08-22 1998-08-21 신속히 붕해되는 메틸셀룰로오스 정제

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1020077027417A Division KR20070116291A (ko) 1997-08-22 1998-08-21 신속히 붕해되는 메틸셀룰로오스 정제

Publications (1)

Publication Number Publication Date
KR20070040424A true KR20070040424A (ko) 2007-04-16

Family

ID=26735831

Family Applications (3)

Application Number Title Priority Date Filing Date
KR1020077007455A Ceased KR20070040424A (ko) 1997-08-22 1998-08-21 신속히 붕해되는 메틸셀룰로오스 정제
KR1020007001825A Expired - Fee Related KR100743767B1 (ko) 1997-08-22 1998-08-21 신속히 붕해되는 메틸셀룰로오스 정제
KR1020077027417A Ceased KR20070116291A (ko) 1997-08-22 1998-08-21 신속히 붕해되는 메틸셀룰로오스 정제

Family Applications After (2)

Application Number Title Priority Date Filing Date
KR1020007001825A Expired - Fee Related KR100743767B1 (ko) 1997-08-22 1998-08-21 신속히 붕해되는 메틸셀룰로오스 정제
KR1020077027417A Ceased KR20070116291A (ko) 1997-08-22 1998-08-21 신속히 붕해되는 메틸셀룰로오스 정제

Country Status (16)

Country Link
US (9) US6350469B1 (cg-RX-API-DMAC7.html)
EP (1) EP1005329A4 (cg-RX-API-DMAC7.html)
JP (1) JP2001513545A (cg-RX-API-DMAC7.html)
KR (3) KR20070040424A (cg-RX-API-DMAC7.html)
CN (2) CN1660054A (cg-RX-API-DMAC7.html)
AR (1) AR017512A1 (cg-RX-API-DMAC7.html)
AU (1) AU741326B2 (cg-RX-API-DMAC7.html)
BR (1) BR9811980A (cg-RX-API-DMAC7.html)
CA (1) CA2301135C (cg-RX-API-DMAC7.html)
CO (1) CO4960651A1 (cg-RX-API-DMAC7.html)
EA (1) EA004803B1 (cg-RX-API-DMAC7.html)
MY (2) MY135183A (cg-RX-API-DMAC7.html)
NZ (1) NZ502891A (cg-RX-API-DMAC7.html)
PL (1) PL338858A1 (cg-RX-API-DMAC7.html)
TW (1) TWI222869B (cg-RX-API-DMAC7.html)
WO (1) WO1999009958A1 (cg-RX-API-DMAC7.html)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR016827A1 (es) 1997-08-22 2001-08-01 Smithkline Beecham Corp PROCEDIMIENTO PARA LA PREPARACIoN DE UNA TABLETA FARMACÉUTICA
AR017512A1 (es) * 1997-08-22 2001-09-12 Smithkline Beecham Corp Tabletas de metilcelulosa rapidamente desintegrables para administracion por via oral y procedimiento para prepararlas
US7022683B1 (en) 1998-05-13 2006-04-04 Carrington Laboratories, Inc. Pharmacological compositions comprising pectins having high molecular weights and low degrees of methoxylation
AU745697B2 (en) * 1998-09-08 2002-03-28 Smithkline Beecham Corporation Lipstatin derivative-soluble fiber tablets
FR2795962B1 (fr) * 1999-07-08 2003-05-09 Prographarm Laboratoires Procede de fabrication de granules enrobes a gout masque et liberation immediate du principe actif
FR2798289B1 (fr) * 1999-09-15 2004-12-31 Cll Pharma Formes galeniques a delitement rapide en bouche et leur procede de preparation
DE19961910A1 (de) 1999-12-20 2001-06-21 Henkel Kgaa Färbemittel
WO2001045647A2 (de) * 1999-12-20 2001-06-28 Henkel Kommanditgesellschaft Auf Aktien Tablettierung verdickender systeme
EP1239816B1 (de) 1999-12-20 2007-11-21 Henkel Kommanditgesellschaft auf Aktien Festförmiges färbemittel für keratinfasern
CN1196463C (zh) 1999-12-20 2005-04-13 汉高两合股份公司 用于角蛋白纤维的固体染色剂
US6777000B2 (en) * 2001-02-28 2004-08-17 Carrington Laboratories, Inc. In-situ gel formation of pectin
US7494669B2 (en) * 2001-02-28 2009-02-24 Carrington Laboratories, Inc. Delivery of physiological agents with in-situ gels comprising anionic polysaccharides
US7670612B2 (en) * 2002-04-10 2010-03-02 Innercap Technologies, Inc. Multi-phase, multi-compartment capsular delivery apparatus and methods for using same
EP1542662A1 (en) * 2002-09-28 2005-06-22 McNEIL-PPC, INC. Immediate release dosage form comprising shell having openings therein
US7232577B2 (en) * 2002-10-21 2007-06-19 L. Perrigo Company Readily dispersible dietary fiber composition
US20040197284A1 (en) * 2003-04-04 2004-10-07 Frederic Auguste Cosmetic composition comprising a volatile fatty phase
US20050019397A1 (en) * 2003-07-23 2005-01-27 Jacobs Richard L. Cellulosic fiber containing composition
FR2858556B1 (fr) * 2003-08-06 2006-03-10 Galenix Innovations Composition pharmaceutique solide dispersible et/ou orodispersible non pelliculee contenant au moins le principe actif metformine, et procede de preparation
JP2005272408A (ja) * 2004-03-26 2005-10-06 Tendou Seiyaku Kk 緩下剤
EP1755556A4 (en) * 2004-05-04 2009-09-30 Innophos Inc DIRECTLY COMPRESSIBLE TRICALCIUM PHOSPHATE
US20060099253A1 (en) * 2004-10-20 2006-05-11 Wyeth Antibiotic product formulation
US7344907B2 (en) * 2004-11-19 2008-03-18 International Business Machines Corporation Apparatus and methods for encapsulating microelectromechanical (MEM) devices on a wafer scale
WO2006085497A1 (ja) * 2005-02-09 2006-08-17 Kissei Pharmaceutical Co., Ltd. 口腔内崩壊錠
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
ES2664895T3 (es) 2006-11-07 2018-04-23 The Procter & Gamble Company Composiciones que contienen fibra y métodos de fabricación y uso de las mismas
US7767248B2 (en) * 2007-02-02 2010-08-03 Overly Iii Harry J Soft chew confectionary with high fiber and sugar content and method for making same
KR100895942B1 (ko) * 2007-05-08 2009-05-07 조선대학교산학협력단 생약 추출물을 함유하는 구강 내 속붕해성 제제 조성물 및그의 제조 방법
WO2009021127A2 (en) * 2007-08-07 2009-02-12 Neurogen Corporation Controlled released compositions
EP2440210A4 (en) * 2009-06-12 2014-01-29 Meritage Pharma Inc METHOD FOR THE TREATMENT OF STOMACH DARM DISEASES
EP2493454A2 (en) 2009-10-28 2012-09-05 McNeil-PPC, Inc. Fast dissolving/disintegrating coating compositions
TWI564008B (zh) 2010-09-30 2017-01-01 鹽野義製藥股份有限公司 難溶性藥物之溶解性改善製劑
NZ704014A (en) * 2012-07-27 2017-10-27 Redhill Biopharma Ltd Formulations and methods of manufacturing formulations for use in colonic evacuation
US10806743B1 (en) * 2017-05-12 2020-10-20 Braintree Laboratories, Inc. Method of administering lactitol to reduce plasma concentration of lactitol
KR20210092613A (ko) 2020-01-16 2021-07-26 안정오 은 생리대 제조방법
IT202100016784A1 (it) * 2021-06-25 2022-12-25 Natural Way Laboratories Srl Composizione per il rilascio di ioni Magnesio

Family Cites Families (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2883327A (en) * 1954-05-03 1959-04-21 Upjohn Co Reducing the gelation of methylcellulose by the addition of a neutral, water-soluble, amino carboxylic acid and product thereof
US3402240A (en) * 1957-06-25 1968-09-17 Pfizer & Co C Medicinal tablet and process of making same
US3039922A (en) * 1959-08-17 1962-06-19 Carter Prod Inc Method of administering tablets having decongestant and anti-histaminic activity
US3147187A (en) * 1962-09-10 1964-09-01 Don Hall Lab Sustained release pharmaceutical
US3622673A (en) * 1968-11-14 1971-11-23 Upjohn Co 4-(1,4,5,6-TETRAHYDROZEPINO 4,5-b INDOL-3(2H)-YL-BUTYROPHENON COMPOSITIONS AND PROCESS OF TREATMENT MENTAL OR EMOTIONAL DISORDERS
DE1931910B2 (de) 1969-06-24 1974-11-28 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur Herstellung fester, steuerbar resorbierbarer Arzneimittelzubereitungen schwer löslicher Wirkstoffe
US3961056A (en) * 1974-02-11 1976-06-01 The Upjohn Company Substituted morpholine guanidines for the treatment of arrhythmic conditions
US3968211A (en) * 1974-02-11 1976-07-06 The Upjohn Company Compositions and methods of use of amidines for anti-arrhythmic purposes
JPS5438167B2 (cg-RX-API-DMAC7.html) * 1974-04-27 1979-11-19
US4048331A (en) * 1974-10-15 1977-09-13 The Upjohn Company Process of treatment
US3969504A (en) * 1975-02-14 1976-07-13 The Upjohn Co. 6-Phenyl benzodiazepine antidepressants
US4048878A (en) * 1976-04-05 1977-09-20 Dresser Industries, Inc. Slip-type pliers tool
US4148879A (en) * 1977-12-23 1979-04-10 Nelson Research & Development Company Inhibition of platelet aggregation with selected phosphonic and phosphinic acid esters
US4148878A (en) * 1977-12-23 1979-04-10 Nelson Research & Development Company Inhibition of platelet aggregation with selected phosphoric acid esters
US4327080A (en) * 1981-07-13 1982-04-27 E. R. Squibb & Sons, Inc. Novel Bendroflumethiazide formulations and method
JPS58144316A (ja) 1982-02-18 1983-08-27 Chiyoda Yakuhin Kk 安定なインドメタシン錠
US4508726A (en) * 1982-09-16 1985-04-02 The Upjohn Company Treatment of panic disorders with alprazolam
ZA841044B (en) 1983-02-17 1984-09-26 Merrell Dow Pharma Dry mix cellulose ether compositions as bulk laxatives
US4517179A (en) * 1983-04-29 1985-05-14 Pennwalt Corporation Rapid dissolving, uniform drug compositions and their preparation
JPS6028915A (ja) 1983-07-26 1985-02-14 Eisai Co Ltd ユビデカレノン高含量含有組成物
US4476134A (en) * 1983-08-01 1984-10-09 The Upjohn Company Process for treating panic disorders
US4849229A (en) * 1984-03-26 1989-07-18 Forest Laboratories, Inc. Controlled release solid drug dosage forms based on mixtures of water soluble nonionic cellulose ethers and anionic surfactants
US4626287A (en) * 1985-01-29 1986-12-02 Merrell Dow Pharmaceuticals Inc. Process for preparing sucrose encrusted methylcellulose particles for use in bulk laxative compositions
JPS6281324A (ja) * 1985-10-03 1987-04-14 Senjiyu Seiyaku Kk 脂肪組織分解剤
US4849227A (en) * 1986-03-21 1989-07-18 Eurasiam Laboratories, Inc. Pharmaceutical compositions
SE8601624D0 (sv) 1986-04-11 1986-04-11 Haessle Ab New pharmaceutical preparations
IT1200178B (it) * 1986-07-23 1989-01-05 Alfa Farmaceutici Spa Formulazioni galeniche a cessione programmata contenenti farmaci ad attivita' antiflogistica
JPH0618774B2 (ja) 1986-10-09 1994-03-16 塩野義製薬株式会社 糖衣錠の製造方法
AU8325987A (en) 1986-12-11 1988-06-30 Upjohn Company, The Antipsychotic amino-polyhydro-benz-(iso)quinolines and intermediates
JPS63222112A (ja) 1987-03-10 1988-09-16 Nippon Soda Co Ltd 徐放性顆粒
JPS63280023A (ja) 1987-05-11 1988-11-17 Yoshitomi Pharmaceut Ind Ltd 抗リウマチ薬
NO883326L (no) * 1987-08-11 1989-02-13 Bayer Ag Dhp-retard-tilberedning.
JPH01168619A (ja) 1987-12-24 1989-07-04 Takada Seiyaku Kk 新規な酢酸クロルマジノン固形製剤
US4866046A (en) * 1988-05-31 1989-09-12 Top Laboratories, Inc. Low-dosage sublingual aspirin
FR2666506A1 (fr) * 1990-09-07 1992-03-13 Pf Medicament Comprime a liberation prolongee a base de 5-mononitrate d'isosorbide et son procede de preparation.
US5292520A (en) * 1990-09-13 1994-03-08 Akzo N.V. Stabilized solid pharmaceutical composition containing acid addition salts of a basic drug and an alkaline stabilizer
DE69013689T2 (de) 1990-11-29 1995-03-02 Wei Ming Pharmaceutical Mfg Co Hilfsträger für direkte Verpressung.
JPH0515319A (ja) 1990-12-14 1993-01-26 Sunstar Inc 水難溶性塩類の分散法およびそれを分散してなる飲用組成物
US5576306A (en) * 1991-03-01 1996-11-19 Dow Chemical Company Pharmaceutical compositions and uses of water-soluble, high-viscosity grade cellulose ethers
US5403593A (en) * 1991-03-04 1995-04-04 Sandoz Ltd. Melt granulated compositions for preparing sustained release dosage forms
JPH05139973A (ja) 1991-11-20 1993-06-08 Shin Etsu Chem Co Ltd ニフエジピン含有固形製剤の製造方法
EP0583470A4 (en) * 1992-01-10 1995-07-26 Obschestvo S Ogranichennoy Otv PHARMACEUTICAL COMPOSITION IN GRANULATE FORM AND PRODUCTION METHOD.
CA2098167C (en) * 1992-06-24 2006-12-19 Dorothea Isler Foodstuffs and feedstuffs containing a lipase inhibitor
IT1255522B (it) * 1992-09-24 1995-11-09 Ubaldo Conte Compressa per impiego terapeutico atta a cedere una o piu' sostanze attive con differenti velocita'
CN1047075C (zh) * 1993-02-26 1999-12-08 普罗克特和甘保尔公司 比沙可啶剂型
DE4333190C2 (de) 1993-09-29 1996-05-30 Korsatko Werner Univ Prof Dr E Zerbeißtablette mit verzögerter Wirkstoff-Freisetzung
US5370878A (en) * 1993-09-30 1994-12-06 Hallmark Pharmaceuticals, Inc. Method for preparing a direct compression granulated acetaminophen composition
EP0724441A1 (en) * 1993-10-19 1996-08-07 The Procter & Gamble Company Picosulphate dosage form
US5496884A (en) * 1993-11-12 1996-03-05 Lord Corporation Aqueous adhesive for bonding elastomers
US5451409A (en) * 1993-11-22 1995-09-19 Rencher; William F. Sustained release matrix system using hydroxyethyl cellulose and hydroxypropyl cellulose polymer blends
TW355683B (en) * 1994-02-17 1999-04-11 Janssen Pharmaceutica Nv Composition containing micronized nebivolol
JPH07267850A (ja) 1994-03-28 1995-10-17 Eisai Co Ltd 不快味を防止した医薬組成物及びその製造方法
US5543099A (en) * 1994-09-29 1996-08-06 Hallmark Pharmaceutical, Inc. Process to manufacture micronized nifedipine granules for sustained release medicaments
GB9501127D0 (en) * 1995-01-20 1995-03-08 Wellcome Found Tablet
US8071128B2 (en) * 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
ES2234139T3 (es) * 1997-08-11 2005-06-16 Alza Corporation Forma de dosificacion de un agente activo de liberacion prolongada adaptada para la retencion gastrica.
AR017512A1 (es) * 1997-08-22 2001-09-12 Smithkline Beecham Corp Tabletas de metilcelulosa rapidamente desintegrables para administracion por via oral y procedimiento para prepararlas
AR016827A1 (es) * 1997-08-22 2001-08-01 Smithkline Beecham Corp PROCEDIMIENTO PARA LA PREPARACIoN DE UNA TABLETA FARMACÉUTICA

Also Published As

Publication number Publication date
AU741326B2 (en) 2001-11-29
PL338858A1 (en) 2000-11-20
CO4960651A1 (es) 2000-09-25
NZ502891A (en) 2002-06-28
KR100743767B1 (ko) 2007-07-30
US20050089562A1 (en) 2005-04-28
EA004803B1 (ru) 2004-08-26
BR9811980A (pt) 2000-08-15
US20020086052A1 (en) 2002-07-04
CN1660054A (zh) 2005-08-31
MY128046A (en) 2007-01-31
US20050089560A1 (en) 2005-04-28
KR20070116291A (ko) 2007-12-07
US20050089563A1 (en) 2005-04-28
AR017512A1 (es) 2001-09-12
US7125562B2 (en) 2006-10-24
US20050089565A1 (en) 2005-04-28
EA200000246A1 (ru) 2000-08-28
AU9202298A (en) 1999-03-16
US6350469B1 (en) 2002-02-26
MY135183A (en) 2008-02-29
KR20010023197A (ko) 2001-03-26
CA2301135C (en) 2007-04-24
US20030215505A1 (en) 2003-11-20
US20050089561A1 (en) 2005-04-28
CN1215833C (zh) 2005-08-24
CN1276719A (zh) 2000-12-13
WO1999009958A1 (en) 1999-03-04
TWI222869B (en) 2004-11-01
EP1005329A4 (en) 2006-06-14
CA2301135A1 (en) 1999-03-04
JP2001513545A (ja) 2001-09-04
US20050089564A1 (en) 2005-04-28
EP1005329A1 (en) 2000-06-07

Similar Documents

Publication Publication Date Title
KR100743767B1 (ko) 신속히 붕해되는 메틸셀룰로오스 정제
CA2301132C (en) Rapidly disintegrating methylcellulose tablets
AU745697B2 (en) Lipstatin derivative-soluble fiber tablets
AU2004237813B2 (en) Rapidly disintegrating methylcellulose tablets
AU779632B2 (en) Rapidly disintegrating methylcellulose tablets
CA2550041A1 (en) Rapidly disintegrating methylcellulose tablets
CA2543223A1 (en) Rapidly disintegrating methylcellulose tablets
MXPA00001857A (en) Rapidly disintegrating methylcellulose tablets
MXPA00001856A (en) Rapidly disintegrating methylcellulose tablets
CZ2000631A3 (cs) Tableta
UA75561C2 (en) Rapidly disintegrated tablets (variants) and process for their manufacture
MXPA01002469A (en) Lipstatin derivative-soluble fiber tablets
CN1981747A (zh) 快速崩解的甲基纤维素片剂

Legal Events

Date Code Title Description
A107 Divisional application of patent
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20070330

PG1501 Laying open of application
A201 Request for examination
AMND Amendment
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20070426

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20070723

Patent event code: PE09021S01D

A107 Divisional application of patent
AMND Amendment
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20071123

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20080305

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20070723

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

J201 Request for trial against refusal decision
PJ0201 Trial against decision of rejection

Patent event date: 20080404

Comment text: Request for Trial against Decision on Refusal

Patent event code: PJ02012R01D

Patent event date: 20080305

Comment text: Decision to Refuse Application

Patent event code: PJ02011S01I

Appeal kind category: Appeal against decision to decline refusal

Decision date: 20080930

Appeal identifier: 2008101003011

Request date: 20080404

AMND Amendment
PB0901 Examination by re-examination before a trial

Comment text: Amendment to Specification, etc.

Patent event date: 20080502

Patent event code: PB09011R02I

Comment text: Request for Trial against Decision on Refusal

Patent event date: 20080404

Patent event code: PB09011R01I

Comment text: Amendment to Specification, etc.

Patent event date: 20071123

Patent event code: PB09011R02I

Comment text: Amendment to Specification, etc.

Patent event date: 20070426

Patent event code: PB09011R02I

B601 Maintenance of original decision after re-examination before a trial
PB0601 Maintenance of original decision after re-examination before a trial

Comment text: Report of Result of Re-examination before a Trial

Patent event code: PB06011S01D

Patent event date: 20080611

J301 Trial decision

Free format text: TRIAL DECISION FOR APPEAL AGAINST DECISION TO DECLINE REFUSAL REQUESTED 20080404

Effective date: 20080930

PJ1301 Trial decision

Patent event code: PJ13011S01D

Patent event date: 20080930

Comment text: Trial Decision on Objection to Decision on Refusal

Appeal kind category: Appeal against decision to decline refusal

Request date: 20080404

Decision date: 20080930

Appeal identifier: 2008101003011